The top 100 stock
market authors
selected for publication in the last week
market authors
selected for publication in the last week
Catapult
»
Comments
| 
Comments by Ticker
1 comment
Rating: 0
(0 
-
0 
)
-
0 )
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Those with the largestSee all
increase in followers
in the last week
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
Sort by:
Latest | Highest ratedWill Myriad Genetics Keep Its Momentum? [View article]
You said "Myriad does have a fairly solid stream of revenues from their current drugs" .... THEY DO NOT HAVE A DRUG ON THE MARKET OR GET ROYALTIES ON A DRUG - they sell diagnostics
YOU SAID "One possible issue that I see for Myriad based solely upon my knowledge of market psychology is that its stock price is very close to its 52 week high" ...WHAT ARE YOU TALKING ABOUT? THEY ARE AT AN ALL TIME HIGH not a "52-Week High".
THIS IS ALL ABOUT AN UGLY SHORT-SQUEEZE on mid-tier diagonostics company with a pipeline for a teazer.